{
    "Status": "Active, not recruiting",
    "Completion Date": "May 31, 2021",
    "Gender": "Female",
    "Outcome Measures": "Distress|Depression|Anxiety|Health related quality of life summary index|Breast cancer related quality of life summary index|Functional related quality of life summary index|Physical health related quality of life|Social health related quality of life|Emotional health related quality of life|Self-efficacy|Fear of recurrence|Pain in the breast surgery area (side of chest, armpit or arm)|Neuropathy in the breast surgery area (side of chest, armpit or arm)|Sleep quality|Cognitive function - Perceived cognitive impairments|Cognitive function- Perceived cognitive impairments|Cognitive function - Impact of Perceived cognitive impairments on quality of life|Cognitive function - Perceived cognitive abilities|Need for support|Health care costs|Acceptability",
    "Last Update Posted": "May 6, 2020",
    "URL": "https://ClinicalTrials.gov/show/NCT03254875",
    "First Posted": "August 21, 2017",
    "Rank": "1",
    "Other IDs": "REBECCA II",
    "Age": "18 Years and older   (Adult, Older Adult)",
    "Interventions": "Behavioral: Individually tailored nurse navigation",
    "Sponsor/Collaborators": "Danish Cancer Society|Rigshospitalet, Denmark|Copenhagen University Hospital at Herlev",
    "Primary Completion Date": "May 31, 2021",
    "Locations": "Rigshospitalet, Copenhagen, Denmark",
    "Results First Posted": "",
    "Acronym": "REBECCA II",
    "Title": "Rehabilitation After Breast Cancer",
    "Study Type": "Interventional",
    "Study Documents": "",
    "Study Results": "No Results Available",
    "Phases": "Not Applicable",
    "Conditions": "Breast Cancer",
    "Enrollment": "324",
    "Funded Bys": "Other",
    "Study Designs": "Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care",
    "Start Date": "August 15, 2017",
    "NCT Number": "NCT03254875"
},
{
    "Enrollment": "0",
    "Sponsor/Collaborators": "Christine Elizabeth Edmonds|Massachusetts General Hospital",
    "Primary Completion Date": "February 28, 2020",
    "Completion Date": "October 31, 2024",
    "Study Designs": "Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic",
    "Results First Posted": "",
    "Last Update Posted": "March 3, 2020",
    "Locations": "Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States",
    "Interventions": "Drug: [11C]Martinostat|Device: MR-PET scanner",
    "URL": "https://ClinicalTrials.gov/show/NCT03721211",
    "Title": "Imaging With [11C]Martinostat in Breast Cancer",
    "Other IDs": "17-447",
    "Acronym": "",
    "NCT Number": "NCT03721211",
    "Outcome Measures": "PET-MRI Visualization and Quantification of Breast Tumor Uptake of [11C]Martinostat Above Background Uptake, as Assessed by SUV Measurements|Quantitative [11C]Martinostat-PET Uptake in Primary Breast Cancer, and Correlation with Expression of HDAC Isoforms|Correlation of Total Volume of Distribution of Dynamic [11C]Martinostat Uptake with Expression of HDAC Isoforms|Comparison of HDAC Isoform Expression by Western Blot Across Breast Tumor Subtypes|HDAC Expression Levels in Breast Tumors Compared to HDAC Expression in Adjacent Normal Breast Parenchyma",
    "Funded Bys": "Other",
    "Start Date": "February 1, 2020",
    "Gender": "Female",
    "Conditions": "Breast Cancer",
    "First Posted": "October 26, 2018",
    "Study Documents": "",
    "Age": "18 Years and older   (Adult, Older Adult)",
    "Status": "Withdrawn",
    "Phases": "Phase 1",
    "Rank": "2",
    "Study Results": "No Results Available",
    "Study Type": "Interventional"
}